Effect of Posterior Corneal Toricity on Refractive Outcome of Pseudophakia

Sponsor
China Medical University, China (Other)
Overall Status
Unknown status
CT.gov ID
NCT01554761
Collaborator
(none)
30
1

Study Details

Study Description

Brief Summary

This study is to evaluate the necessity of considering posterior corneal toricity on refractive outcome of patients with cataracts and corneal astigmatism after implantation of intraocular lenses.

This is determined by comparing total corneal and refractive astigmatism,and by comparing the expected refractive result with actual refractive astigmatism postoperatively,using total corneal and anterior corneal astigmatism to calculate respectively.

Condition or Disease Intervention/Treatment Phase
  • Procedure: phacoemulsification
  • Device: Pentacam (Oculus,Germany)examination
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Posterior Corneal Toricity on Refractive Outcome of Pseudophakia
Study Start Date :
Feb 1, 2012
Anticipated Primary Completion Date :
May 1, 2012

Outcome Measures

Primary Outcome Measures

  1. Pentacam-derived corneal astigmatism [3month postoperatively]

  2. refraction [3month postoperatively]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • cataract candidates

  • preoperative corneal regular astigmatism >0.75D

  • Willing and able to complete all required postoperative visits

  • Able to comprehend and sign a statement of informed consent

Exclusion Criteria:
  • significant intraocular lenses tilt or decentration

  • corneal scarring

  • Irregular corneal astigmatism

  • other ocular diseases

  • surgical complication

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eye hospital of China Medical Univerisity Shenyang Liaoning China 110005

Sponsors and Collaborators

  • China Medical University, China

Investigators

  • Principal Investigator: Jinsong Zhang, MD, Eye Hospital of China Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jinsong Zhang, MD,the President of Eye hosptial of China Medical Univerisity,China, China Medical University, China
ClinicalTrials.gov Identifier:
NCT01554761
Other Study ID Numbers:
  • 2
First Posted:
Mar 15, 2012
Last Update Posted:
Mar 15, 2012
Last Verified:
Mar 1, 2012
Keywords provided by Jinsong Zhang, MD,the President of Eye hosptial of China Medical Univerisity,China, China Medical University, China
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2012